IFATS collection: Immunomodulatory effects of adipose tissue-derived stem cells in an allergic rhinitis mouse model

Stem Cells

Volumn 27, Issue 1, 2009, Pages 259-265

  Cho, Kyu Sup ^a   Park, Hye Kyung ^a   Park, Hee Young ^a   Jin, Sup Jung ^b   Jeon, Seong Gyu ^c   Kim, Yoon Keun ^c   Hwan, Jung Roh ^a,b  

^a Institute of Allergy and Clinical Immunology   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

Adipose tissue; Allergic rhinitis; Immunosuppression; Mice; Stem cells

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN;

ADIPOSE TISSUE CELL; ALLERGIC RHINITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSIVE ELEMENT; FEMALE; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; IMMUNOPHENOTYPING; INTERFERON PRODUCTION; MOUSE; NONHUMAN; NOSE MUCOSA; SPLEEN CELL; STEM CELL;

ADIPOSE TISSUE; ANIMALS; ANTIBODY FORMATION; CELL COUNT; CELL DIFFERENTIATION; CYTOKINES; DISEASE MODELS, ANIMAL; EPITOPES; FEMALE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; IMMUNOPHENOTYPING; MICE; MICE, INBRED BALB C; NASAL MUCOSA; OVALBUMIN; RHINITIS, ALLERGIC, PERENNIAL; SPLEEN; STEM CELLS;

MUS;

EID: 59849120888     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2008-0283     Document Type: Article

References (24)

1. Delorme B, Charbord P. Culture and characterization of human bone marrow mesenchymal stem cells. Methods Mol Med 2007;140:67-81.
2. Liu TM, Martina M, Hutmacher DW et al. Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. STEM CELLS 2007;25:750-760.
3. Titorencu I, Jinga VV, Constantinescu E et al. Proliferation, differentiation and characterization of osteoblasts from human BM mesenchymal cells. Cytotherapy 2007;9:682-696.
4. Bhagavati S, Xu W. Isolation and enrichment of skeletal muscle progenitor cells from mouse bone marrow. Biochem Biophys Res Commun 2004;318:119-124.
5. Horwitz EM, Prockop DJ, Gordon PL et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 2001;97:1227-1231.
6. Shake JG, Gruber PJ, Baumgartner WA et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: Engraftment and functional effects. Ann Thorac Surg 2002;73:1919-1926.
7. Rojas M, Xu J, Woods CR et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005;33:145-152.
8. Li Y, Chen J, Chen XG et al. Human marrow stromal cell therapy for stroke in rat: Neurotrophins and functional recovery. Neurology 2002;59:514-523.
9. Le Blanc K, Rasmusson I, Sundberg B et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-1441.
10. + regulatory T cells. STEM CELLS 2008;26:212-222.
11. Spaggiari GM, Capobianco A, Abdelrazik H et al. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: Role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 2008;111:1327-1333.
12. English K, Barry FP, Mahon BP. Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation. Immunol Lett 2008;115:50-58.
13. Lee RH, Kim B, Choi I et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 2004;14:311-324.
14. Bunnell BA, Estes BT, Guilak F et al. Differentiation of adipose stem cells. Methods Mol Biol 2008;456:155-171.
15. Puissant B, Barreau C, Bourin P et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: Comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005;129:118-129.
16. Bochev I, Elmadjian G, Kyurkchiev D et al. Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro. Cell Biol Int 2008;32:384-393.
17. Cui L, Yin S, Liu W et al. Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2. Tissue Eng 2007;13:1185-1195.
18. Wilson MS, Taylor MD, Balic A et al. Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J Exp Med 2005;202:1199-1212.
19. Park Y, Chang YS, Lee SW et al. The enhanced effect of a hexameric deoxyriboguanosine run conjugation to CpG oligodeoxynucleotides on protection against allergic asthma. J Allergy Clin Immunol 2001;108:570-576.
20. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res 2007;100:1249-1260.
21. Kern S, Eichler H, Stoeve J et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. STEM CELLS 2006;24:1294-1301.
22. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815-1822.
23. Di Nicola M, Carlo-Stella C, Magni M et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99:3838-3843.
24. Jiang XX, Zhang Y, Liu B et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005;105:4120-4126.